MXPA03007838A - Interferon alfa modificado con inmunogenicidad reducida. - Google Patents
Interferon alfa modificado con inmunogenicidad reducida.Info
- Publication number
- MXPA03007838A MXPA03007838A MXPA03007838A MXPA03007838A MXPA03007838A MX PA03007838 A MXPA03007838 A MX PA03007838A MX PA03007838 A MXPA03007838 A MX PA03007838A MX PA03007838 A MXPA03007838 A MX PA03007838A MX PA03007838 A MXPA03007838 A MX PA03007838A
- Authority
- MX
- Mexico
- Prior art keywords
- interferon alpha
- reduced immunogenicity
- modified interferon
- modified
- immunogenicity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01105088 | 2001-03-02 | ||
PCT/EP2002/002218 WO2002085941A2 (en) | 2001-03-02 | 2002-03-01 | Modified interferon alpha with reduced immunogenicity |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03007838A true MXPA03007838A (es) | 2003-12-08 |
Family
ID=8176646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03007838A MXPA03007838A (es) | 2001-03-02 | 2002-03-01 | Interferon alfa modificado con inmunogenicidad reducida. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20060062761A1 (es) |
EP (1) | EP1379555A2 (es) |
JP (1) | JP2004535173A (es) |
KR (1) | KR20030081479A (es) |
CN (1) | CN1529714A (es) |
BR (1) | BR0207704A (es) |
CA (1) | CA2439690A1 (es) |
HU (1) | HUP0303309A2 (es) |
MX (1) | MXPA03007838A (es) |
PL (1) | PL363181A1 (es) |
RU (1) | RU2003129056A (es) |
WO (1) | WO2002085941A2 (es) |
ZA (1) | ZA200307677B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003277088A1 (en) * | 2002-10-01 | 2004-04-23 | Xencor, Inc | Interferon variants with improved properties |
MXPA05008704A (es) * | 2003-02-18 | 2005-10-05 | Merck Patent Gmbh | Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas. |
US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
US20090010966A1 (en) * | 2007-06-21 | 2009-01-08 | Angelica Therapeutics, Inc. | Modified diphtheria toxins |
EP2268297A4 (en) * | 2008-02-29 | 2011-11-16 | Angelica Therapeutics Inc | MODIFIED TOXINS |
US20110224407A1 (en) * | 2008-09-09 | 2011-09-15 | University Of Medicine And Dentistry Of New Jersey | Type I Interferon Antagonists |
US10059750B2 (en) | 2013-03-15 | 2018-08-28 | Angelica Therapeutics, Inc. | Modified toxins |
CN105255840A (zh) * | 2015-10-16 | 2016-01-20 | 西安医学院 | 通过去除显性表位b8r重组痘苗病毒的方法及其病毒 |
CN105200017A (zh) * | 2015-10-16 | 2015-12-30 | 西安医学院 | 一种去除a47l降低痘苗病毒免疫优势的方法及病毒 |
AU2018258061A1 (en) | 2017-04-28 | 2019-11-28 | National Jewish Health | Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene |
AR117715A1 (es) * | 2019-12-17 | 2021-08-25 | Univ Nacional Del Litoral Unl | Interferón hiperglicosilado con inmunogenicidad reducida |
JP2024517475A (ja) * | 2021-05-10 | 2024-04-22 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイト | 自己免疫を治療するための操作されたhla対立遺伝子 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU728146B2 (en) * | 1996-03-14 | 2001-01-04 | Immune Response Corporation, The | Targeted delivery of genes encoding interferon |
-
2002
- 2002-03-01 BR BR0207704-3A patent/BR0207704A/pt not_active IP Right Cessation
- 2002-03-01 CN CNA028058658A patent/CN1529714A/zh active Pending
- 2002-03-01 HU HU0303309A patent/HUP0303309A2/hu unknown
- 2002-03-01 JP JP2002583467A patent/JP2004535173A/ja active Pending
- 2002-03-01 PL PL02363181A patent/PL363181A1/xx unknown
- 2002-03-01 KR KR10-2003-7011451A patent/KR20030081479A/ko not_active Application Discontinuation
- 2002-03-01 MX MXPA03007838A patent/MXPA03007838A/es unknown
- 2002-03-01 EP EP02727340A patent/EP1379555A2/en not_active Withdrawn
- 2002-03-01 RU RU2003129056/13A patent/RU2003129056A/ru not_active Application Discontinuation
- 2002-03-01 US US10/469,679 patent/US20060062761A1/en not_active Abandoned
- 2002-03-01 WO PCT/EP2002/002218 patent/WO2002085941A2/en not_active Application Discontinuation
- 2002-03-01 CA CA002439690A patent/CA2439690A1/en not_active Abandoned
-
2003
- 2003-10-01 ZA ZA200307677A patent/ZA200307677B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002085941A2 (en) | 2002-10-31 |
RU2003129056A (ru) | 2005-04-20 |
PL363181A1 (en) | 2004-11-15 |
US20060062761A1 (en) | 2006-03-23 |
KR20030081479A (ko) | 2003-10-17 |
WO2002085941A3 (en) | 2003-10-30 |
CA2439690A1 (en) | 2002-10-31 |
EP1379555A2 (en) | 2004-01-14 |
HUP0303309A2 (hu) | 2003-12-29 |
JP2004535173A (ja) | 2004-11-25 |
ZA200307677B (en) | 2004-07-13 |
BR0207704A (pt) | 2004-07-06 |
CN1529714A (zh) | 2004-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03007323A (es) | Proteinas artificiales con inmunogenicidad reducida. | |
MXPA03007319A (es) | Anticuerpos contra egfr modificados, con inmunogenicidad reducida. | |
MXPA03008961A (es) | Composicion de vacuna. | |
ZA200208561B (en) | Hydraulischer druckverstarker. | |
MXPA01009037A (es) | I-bet. | |
MXPA03008310A (es) | Interferon beta modificado con inmunogenicidad reducida. | |
MXPA03007915A (es) | Vacuna. | |
MXPA03008164A (es) | Agentes anti-epileptogenos. | |
MXPA03007838A (es) | Interferon alfa modificado con inmunogenicidad reducida. | |
MXPA03006989A (es) | Leptina modificada con inmunogenicidad reducida. | |
HK1049770A1 (en) | Fan. | |
HUP0303430A3 (en) | Modified protamine with reduced immunogenicity | |
GB0130812D0 (en) | Messaging arrangement | |
MXPA03007625A (es) | Trombopoyetina modificada con inmunogenicidad reducida. | |
PL372202A1 (en) | Modified byrodin 1 with reduced immunogenicity | |
MXPA03008402A (es) | Insulina modificada con inmunogenicidad reducida. | |
ZA200307645B (en) | Recombinant dimorphic fungal cell. | |
GB2383044B (en) | Alstroem syndrome gene | |
MXPA03008086A (es) | Protamina modificada con inmunogenicidad reducida. | |
GB2384585B (en) | Digital Clipboard | |
AU2001255380A1 (en) | Human interferon, zinf2 | |
GB0112516D0 (en) | V.i.s.c | |
ZA200210073B (en) | Arm-rest. | |
GB0002981D0 (en) | Interferon alpha inuced gene | |
ZA200207799B (en) | Impeller. |